A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Summary

This Phase IIa, randomized, double-blind, placebo-controlled, parallel group study will evaluate the safety, efficacy and pharmacodynamics of basmisanil in adult participants with severe motor impairment following an ischemic stroke.

Timeline

Start

2017-02-20

Primary completion

2017-11-03

Completion

2017-11-03

Outcome

Outcome not reported

Stopped (Enrollment): “Low participant enrolment”

Drugs

Indications